JUL 14, 2016 6:00 AM PDT

Innovations in Hepatology: Biomarkers for Hepatocellular Carcinoma in Surveillance and Management of patients with Chronic Liver Disease

Speaker
  • Chair of Gastroenterology Fellowship Research Committee, Associate Professor of Clinical Science, UT Southwestern Medical Center
    BIOGRAPHY

Abstract

Hepatocellular Carcinoma (HCC), the third leading cause of global cancer mortality, continues to be a substantial burden to health systems, society and individuals at risk. Although prognosis is poor among most patients with HCC, with 5-year survival rates below 10%, frequent monitoring of at-risk patients is associated with improved early detection and survival rates. Patients with cirrhosis from any cause, including chronic hepatitis C, hepatitis B, and nonalcoholic steatohepatitis, may benefit from screening regimens, such as ultrasonography and serum biomarker monitoring. To date, abdominal ultrasound with or without alpha fetoprotein (AFP) is the preferred method for HCC screening in high-risk patients.

Despite the relative low cost and non-invasive nature of these techniques, there is a potential opportunity to improve sensitivity and specificity of HCC detection by leveraging newly available serum biomarkers. PIVKA-II, also known as DCP, is a modified prothrombin that lacks the activity of interacting with other coagulation factors and is expressed in HCC cells. PIVKA-II has been used alongside ultrasound and AFP for HCC screening programs and HCC diagnosis in certain geographies (i.e. Japan).

During this webinar we will review the epidemiological and clinical landscape of hepatocellular carcinoma. We will discuss current challenges and opportunities in HCC surveillance and patient management, including the role of biomarkers, including AFP and PIVKA-II.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
MAY 18, 2021 7:00 AM PDT
MAY 18, 2021 7:00 AM PDT
Date: May 18, 2021 Time: 7:00am PDT, 10:00am EDT Proteins encoded by mutant genes in cancers can be processed and presented on tumor cell surface by human leukocyte antigen (HLA) molecules,...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
Loading Comments...
Show Resources